Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TransMedics Group, Inc.TMDX · Entity 4261 | Chief Financial Officer | July 10, 2026 | July 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TransMedics Group, Inc.
Report date July 10, 2026 · Filed July 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,935 |
Reported balance
After 2026-07-10 transaction · row 1
1 source rowRow 1 · 2026-07-10 · Grant · Acquired 17,246 · Balance 31,935 F1: Consists of 17,246 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.23 · Expires 2036-07-10 | Direct | 26,153 |
Reported balance
After 2026-07-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-10 · Grant · Acquired 26,153 · Balance 26,153 F2: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following April 10, 2026 until the option is fully vested on April 10, 2030, subject to continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of 17,246 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following April 10, 2026 until the option is fully vested on April 10, 2030, subject to continued service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 10, 2026 Filed Jul 15, 2026 01:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 26,153 | $0.00 Strike: $71.23 | $0.00 |
DisclosureSEC source: 0001193125-26-303710 · ownership.xml · derivative · entry 2 Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,153 Underlying: Common Stock · 26,153 shares Expires 2036-07-10 F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following April 10, 2026 until the option is fully vested on April 10, 2030, subject to continued service. Read SEC document |
| July 10, 2026 Filed Jul 15, 2026 01:33 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantCommon Stock | 17,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-303710 · ownership.xml · nonDerivative · entry 1 Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,935 F1 · kind: Consists of 17,246 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 02:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,912 | $0.00 Strike: $69.84 | $0.00 |
DisclosureSEC source: 0001193125-26-092241 · ownership.xml · derivative · entry 7 Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,010 Underlying: Common Stock · 5,912 shares Expires 2034-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested as to 25% of the shares underlying the option on December 2, 2025 and will continue to vest as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 02:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,324 | $0.00 Strike: $77.12 | $0.00 |
DisclosureSEC source: 0001193125-26-092241 · ownership.xml · derivative · entry 6 Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,975 Underlying: Common Stock · 1,324 shares Expires 2035-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 02:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 5,912 | $147.21 | $870,305.52 |
DisclosureSEC source: 0001193125-26-092241 · ownership.xml · nonDerivative · entry 5 Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,689 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $147.14 to $147.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 02:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 5,912 | $69.84 | $412,894.08 |
DisclosureSEC source: 0001193125-26-092241 · ownership.xml · nonDerivative · entry 4 Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 02:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 1,324 | $147.21 | $194,906.04 |
DisclosureSEC source: 0001193125-26-092241 · ownership.xml · nonDerivative · entry 3 Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,689 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $147.14 to $147.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 02:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | Exercise / conversionCommon Stock | 1,324 | $77.12 | $102,106.88 |
DisclosureSEC source: 0001193125-26-092241 · ownership.xml · nonDerivative · entry 2 Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 02:40 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 375 | $139.12 | $52,170.00 |
DisclosureSEC source: 0001193125-26-092241 · ownership.xml · nonDerivative · entry 1 Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,689 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 21:30 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | SaleCommon Stock | 920 | $139.62 | $128,450.40 |
DisclosureSEC source: 0001193125-25-309750 · ownership.xml · nonDerivative · entry 1 Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,064 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 23:15 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 5,299 | $0.00 Strike: $77.12 | $0.00 |
DisclosureSEC source: 0000950170-25-028063 · ownership.xml · derivative · entry 2 Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,299 Underlying: Common Stock · 5,299 shares Expires 2035-02-24 F2 · derivative.exercise_date: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 23:15 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantCommon Stock | 3,521 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028063 · ownership.xml · nonDerivative · entry 1 Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,984 F1 · shares: Consists of 3,521 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 23:48 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantStock Option (Right to Buy) · Derivative | 18,922 | $0.00 Strike: $69.84 | $0.00 |
DisclosureSEC source: 0000950170-24-135528 · ownership.xml · derivative · entry 2 Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,922 Underlying: Common Stock · 18,922 shares Expires 2034-12-09 F2 · derivative.exercise_date: The option vests as to 25% of the shares underlying the option on December 2, 2025 and as to the remaining shares in equal monthly installments over three years thereafter, subject to Reporting Persons' continued service to the Issuer. Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 23:48 UTC | TransMedics Group, Inc. TMDX · Entity 4261 | GrantCommon Stock | 12,463 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-135528 · ownership.xml · nonDerivative · entry 1 Hernandez Gerardo · CIK 0002046180 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,463 F1 · shares: Consists of 12,463 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.